Close Menu

NEW YORK (360Dx) – T2 Biosystems announced today that it has received market clearance from the US Food and Drug Administration for its T2Bacteria Panel.

The T2Bacteria panel detects species of bacteria in whole blood samples from patients with potential bloodstream infections in roughly five hours.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.